Dr. Lal PathLabs Q4 Results: Profit Rises 83%, Beats Estimates
Dr. Lal PathLabs' revenue rose 10.5% to Rs 602.60 crore in comparison to Rs 545.40 reported in the same period last fiscal.
Dr. Lal PathLabs Ltd.’s fourth quarter profit increased, beating analysts' estimates.
The diagnostic and healthcare testing services provider’s net profit rose 83% year-on-year to Rs 154.80 crore in the quarter ended March 31, 2025, according to its exchange filing. That compares with the Rs 99.5-crore consensus estimate of analysts tracked by Bloomberg.
Dr. Lal PathLabs Q4 FY25 Highlights (YoY)
Revenue up 10.5% at Rs 602.60 crore versus Rs 545.40 crore (Bloomberg estimate: Rs 604.2 crore).
Ebitda up 17% at Rs 169 crore versus Rs 144.70 crore (Bloomberg estimate: Rs 158.9 crore).
Ebitda margin at 28% versus 26.5% (Bloomberg estimate: 26.3%).
Net profit up 83% at Rs 154.80 crore versus Rs 84.50 crore (Bloomberg estimate: 99.5 crore).
Shares of Dr. Lal PathLabs were trading 0.36% higher, as compared with a 0.62% decline in the benchmark Nifty 50.
(This is a developing story).
